secwatch.observer — SEC 8-K summary
======================================

Issuer:     Prime Medicine, Inc. (PRME)
CIK:        0001894562
Form:       8-K
Filed at:   2026-06-08T20:10:17+00:00
Accession:  0001628280-26-041543
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Prime Medicine shareholders elect directors, ratify auditor at 2026 annual meeting
--------------------------------------------------------------------------------

- Michael Kelly elected Class I director: 107,059,058 for, 3,047,945 withheld, 30,277,721 broker non-votes.
- David Schenkein, M.D. elected Class I director: 87,522,409 for, 22,584,594 withheld, 30,277,721 broker non-votes.
- Ratification of PricewaterhouseCoopers as auditor approved: 139,989,201 for, 101,259 against, 294,264 abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1894562/000162828026041543/0001628280-26-041543-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1894562/000162828026041543/prme-20260605.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-041543

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer